Verify fasting for at least 6-8 hours. Review coagulation profile (INR/PTT) and platelet count. Ensure informed consent is signed. Administer topical oropharyngeal anesthetic spray if indicated.
Monitor vital signs for 1-2 hours post-procedure. Initiate clear liquid diet after 4-6 hours if no dysphagia. Discharge on the same day with instructions to avoid strenuous activity, alcohol, and non-steroidal anti-inflammatory drugs (NSAIDs) for 7-14 days.
Comprehensive Guide: Endoscopic Hemostasis via Band Ligation for Esophageal Varices
1. Introduction & Clinical Overview
Endoscopic Variceal Band Ligation (EVL) represents the gold standard in the management of esophageal varices, particularly in the setting of portal hypertension and cirrhosis. As an expert clinical procedure, EVL utilizes mechanical strangulation of variceal vessels to achieve hemostasis or provide prophylactic therapy against hemorrhage. Unlike older methods such as sclerotherapy, which involved the injection of chemical agents, EVL relies on the application of elastic bands to the variceal column, effectively inducing necrosis and subsequent fibrosis. This guide provides an exhaustive clinical overview of the procedure, its technical nuances, and the post-procedural management required for patient safety.
2. Technical Specifications & Mechanism of Action
The core mechanism of EVL is the creation of a mechanical "strangulation" of the variceal tissue. By suctioning the varix into a small cylinder attached to the distal end of the endoscope and deploying a rubber band, the practitioner cuts off blood flow to the vessel.
The Ligation Apparatus
- The Multi-Band Ligator: Modern devices typically allow for the deployment of 6 to 10 bands per device, eliminating the need for repeated endoscope withdrawal between ligations.
- Suction Mechanism: The suction pressure is critical; it must be sufficient to draw the varix and a small portion of the surrounding mucosa into the cap without causing perforation of the esophageal wall.
- Deployment Trigger: A trip-wire mechanism allows the endoscopist to release the band once the target tissue is adequately captured within the cap.
The Pathophysiological Sequence
- Suction: Varix is drawn into the ligation chamber.
- Ligation: The elastic band is deployed, compressing the varix and the mucosa.
- Necrosis: Ischemia occurs rapidly, leading to tissue necrosis within 24–48 hours.
- Ulceration: Sloughing of the necrotic tissue leaves a shallow, localized ulcer.
- Fibrosis: Healing of the ulcer results in fibrosis and vessel obliteration, effectively preventing further bleeding.
3. Clinical Indications & Usage
EVL is categorized into two primary clinical applications: Primary Prophylaxis and Secondary Prophylaxis (or Acute Hemostasis).
Primary Prophylaxis
Indicated for patients with cirrhosis who have not yet bled but are at high risk of hemorrhage. High-risk markers include:
- Large esophageal varices (>5mm).
- "Red wale" markings on the varices (indicative of thin vessel walls).
- Child-Pugh Class C cirrhosis.
Secondary Prophylaxis & Acute Hemostasis
Indicated for patients who have already experienced a variceal hemorrhage. EVL is the preferred method for active bleeding, provided the bleeding source can be visualized and the patient is hemodynamically stabilized.
Clinical Decision Matrix
| Condition | Preferred Intervention | Rationale |
|---|---|---|
| Small, Low-Risk Varices | Beta-blockers (Pharmacotherapy) | Lower risk profile; avoid invasive procedure |
| Large, High-Risk Varices | EVL | High efficacy in preventing first bleed |
| Acute Variceal Bleed | EVL + Pharmacotherapy | Mechanical control + reduction of portal pressure |
| Gastric Varices | Cyanoacrylate Glue Injection | EVL is less effective for gastric variceal anatomy |
4. Pre-Operative Preparation
Success in EVL is heavily dependent on meticulous patient preparation.
- Stabilization: In acute cases, hemodynamic resuscitation with blood products (to maintain Hb > 7g/dL) and fluids is the first priority.
- Pharmacotherapy: Intravenous octreotide or somatostatin should be initiated to reduce splanchnic blood flow and portal pressure.
- Antibiotic Prophylaxis: Mandatory. Patients with cirrhosis and GI bleeding are at high risk for spontaneous bacterial peritonitis (SBP). Ceftriaxone (1g IV) is the standard of care.
- Coagulation Status: Assessment of INR and platelets. While correction is ideal, EVL can often be performed in the presence of mild-to-moderate coagulopathy.
- Sedation: Standard conscious or deep sedation (Propofol) is typically utilized, requiring fasting for at least 6–8 hours.
5. The Procedure: Step-by-Step Execution
- Endoscopic Inspection: Perform a thorough esophagogastroduodenoscopy (EGD) to identify the size, location, and presence of "red signs."
- Ligator Attachment: The device is attached to the tip of the endoscope. Ensure the trip-wire is unobstructed.
- Targeting: Begin ligation at the gastroesophageal junction (GEJ) and work proximally in a spiral fashion to avoid obscuring the view with blood or mucosal debris.
- Suction and Deployment:
- Position the cap over the varix.
- Apply suction until the mucosa/varix is fully engaged (the "red-out" sign).
- Deploy the band.
- Verification: Confirm the successful capture of the varix (the "pseudo-polyp" appearance).
- Withdrawal: Carefully remove the endoscope to avoid premature dislodgement of the bands.
6. Post-Operative Recovery & Monitoring
- Observation: Monitor vital signs for 2–4 hours post-procedure.
- Dietary Progression: Patients are typically kept NPO for 4–6 hours, followed by a liquid diet for 24 hours, and then soft foods for 3–7 days to prevent mechanical dislodgement of the bands.
- Pain Management: Dysphagia and retrosternal chest pain are common (due to esophageal spasm). Sucralfate slurry or proton pump inhibitors (PPIs) are often prescribed to facilitate ulcer healing.
- Follow-up: Repeat EGD is usually scheduled for 2–4 weeks later to assess for residual varices and perform repeat ligation if necessary.
7. Risks, Complications, and Contraindications
Potential Complications
- Post-Ligation Ulcer Bleeding: Occurs in 5–10% of patients, usually 5–10 days post-procedure when the necrotic tissue sloughs off.
- Esophageal Stricture: A rare complication resulting from excessive fibrosis after multiple sessions.
- Esophageal Perforation: Rare (<1%), but catastrophic. Often associated with improper suction or patient movement.
- Bacteremia: Transient and usually asymptomatic, though antibiotic prophylaxis mitigates this risk.
Contraindications
- Absolute: Severe esophageal stricture preventing scope passage; uncorrected coagulopathy (where risk outweighs benefit); patient refusal.
- Relative: Unstable hemodynamic status (unless the procedure is life-saving); active severe esophagitis.
8. Alternative Treatments
While EVL is the gold standard, alternatives exist for specific scenarios:
1. Endoscopic Sclerotherapy: Injection of sclerosants (e.g., ethanolamine). Largely replaced by EVL due to higher complication rates (ulceration, strictures).
2. TIPS (Transjugular Intrahepatic Portosystemic Shunt): A radiological intervention that lowers portal pressure. Used for patients who fail EVL or have refractory bleeding.
3. Balloon Tamponade: A temporary, "bridge-to-treatment" measure (e.g., Sengstaken-Blakemore tube) for massive, uncontrollable hemorrhage.
4. Pharmacotherapy: Non-selective beta-blockers (Propranolol/Nadolol) remain the cornerstone of long-term portal hypertension management.
9. Frequently Asked Questions (FAQ)
1. How long do the bands stay on?
The bands typically fall off within 7 to 14 days as the tissue underneath necroses and heals. They are passed naturally through the GI tract.
2. Is the procedure painful?
Most patients report mild discomfort or a feeling of "fullness" in the chest, but severe pain is uncommon. Sedation is used to ensure patient comfort.
3. What is the success rate of EVL?
EVL is highly effective, with an acute hemostasis rate of over 90% for active variceal bleeding.
4. Can I eat normally immediately after the procedure?
No. Patients must follow a strict liquid-to-soft diet for several days to prevent the bands from being scraped off by solid food.
5. Why are PPIs prescribed after EVL?
PPIs are used to reduce gastric acidity, which helps in the healing of the post-ligation ulcers and reduces the risk of secondary bleeding.
6. How many sessions are usually required?
Typically, 3 to 4 sessions spaced 2–4 weeks apart are required to achieve complete variceal eradication.
7. Can EVL be used for gastric varices?
Generally, no. Gastric varices are often too large or have high-flow dynamics that make banding risky or ineffective. Cyanoacrylate glue is the standard for gastric varices.
8. What are the warning signs of a complication?
Patients should seek immediate care if they experience hematemesis (vomiting blood), melena (black, tarry stools), or severe, unrelenting chest pain.
9. Does EVL cure cirrhosis?
No. EVL treats the manifestation of portal hypertension (varices) but does not reverse the underlying liver disease or cirrhosis.
10. What is the risk of recurrence?
Varices can recur, especially if the underlying portal hypertension is not managed with medications (beta-blockers) or if the liver disease progresses. Regular surveillance is essential.
10. Conclusion
Endoscopic Hemostasis via Band Ligation is a life-saving intervention that has significantly improved the prognosis for patients with esophageal varices. By combining mechanical precision with a structured follow-up protocol, clinicians can effectively prevent fatal hemorrhages and manage acute crises. Success, however, relies on the synergy between the endoscopist's technical skill, the nursing team's vigilance, and the patient's adherence to post-procedural dietary and medication protocols. As medical technology advances, the refinement of ligation devices continues to enhance the safety and efficiency of this essential orthopedic and gastroenterological procedure.